Who is the CEO of Flexion Therapeutics, Inc.?

Key leadership information for Flexion Therapeutics, Inc., including the current CEO, is detailed in the company's official annual reports and proxy statements.

What industry does Flexion Therapeutics, Inc. belong to?

Flexion Therapeutics, Inc. operates in the Asset Management industry within the Financial Services sector.

Where is Flexion Therapeutics, Inc. headquartered?

Flexion Therapeutics, Inc. is headquartered at US.

What is the IPO date of Flexion Therapeutics, Inc.?

Flexion Therapeutics, Inc. went public on July 3, 2025.

How many employees does Flexion Therapeutics, Inc. have?

The total number of employees at Flexion Therapeutics, Inc. is disclosed periodically in the company's annual financial reports.

Flexion Therapeutics, Inc.

FLXN•NASDAQ

Financial Services

Asset Management

$25.17

$0.02(0.10%)

Flexion Therapeutics, Inc. (FLXN) Company Profile & Overview

Explore Flexion Therapeutics, Inc.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Flexion Therapeutics, Inc. (FLXN) Company Profile & Overview

An actively managed fixed-income ETF focusing primarily on high-yield (non-investment-grade) bonds with dynamic exposure shifts and options overlays (e.g., put spreads, collars) for current income and risk management

SectorFinancial Services

IndustryAsset Management

Company Facts

IPO DateJul 3, 2025

CountryUS

Actively Trading

Frequently Asked Questions

;